162 related articles for article (PubMed ID: 16146273)
1. Orbital metastasis as a first indication of prostate cancer: a case report.
Autorino R; Zito A; Di Giacomo F; Cosentino L; Quarto G; Di Lorenzo G; Mordente S; Pane U; Giordano A; D'Armiento M
Arch Ital Urol Androl; 2005 Jun; 77(2):109-10. PubMed ID: 16146273
[TBL] [Abstract][Full Text] [Related]
2. Proptosis of eye: an atypical presentation of prostatic malignancy.
Amjad A; Osmani AH; Haider G
J Coll Physicians Surg Pak; 2015 Apr; 25 Suppl 1():S39-40. PubMed ID: 25933459
[TBL] [Abstract][Full Text] [Related]
3. [Prostatic cancer with multiple pulmonary metastases treated successfully with hormonal therapy: a case report].
Fukuda M; Takashima H; Fuse H; Hirano S
Hinyokika Kiyo; 2002 Aug; 48(8):499-502. PubMed ID: 12243078
[TBL] [Abstract][Full Text] [Related]
4. Proptosis--an uncommon presentation of orbital metastases secondary to prostate cancer.
Vissamsetti B; McArdle PA; Adams CJ; Hotiana Z; Morton AL; Alexander RJ
Urol Int; 2007; 79(4):374-5; discussion 375. PubMed ID: 18025861
[TBL] [Abstract][Full Text] [Related]
5. [Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case].
Deme D; Ragán M; Kalmár K; Kovács L; Varga E; Varga T; Rakonczai E
Magy Onkol; 2010 Dec; 54(4):351-7. PubMed ID: 21163766
[TBL] [Abstract][Full Text] [Related]
6. [Small cell carcinoma of the prostate: a case report].
Sakai H; Tsuruta T; Wajiki M
Hinyokika Kiyo; 2004 Apr; 50(4):269-71. PubMed ID: 15188622
[TBL] [Abstract][Full Text] [Related]
7. Prostate-cancer-specific survival and clinical progression-free survival in men with prostate cancer treated intermittently with testosterone-inactivating pharmaceuticals.
Scholz M; Lam R; Strum S; Jennrich R; Johnson H; Trilling T
Urology; 2007 Sep; 70(3):506-10. PubMed ID: 17905106
[TBL] [Abstract][Full Text] [Related]
8. [Regression of a choroidal metastasis from prostate adenocarcinoma after hormonal therapy].
Barbón JJ; González-Tuero J; Gay LL; Pérez-García FJ; Sampedro A
Arch Soc Esp Oftalmol; 2007 Nov; 82(11):715-7. PubMed ID: 17979041
[TBL] [Abstract][Full Text] [Related]
9. A case of orbital metastasis from prostatic carcinoma as an initial symptom.
Isshiki S; Cho S; Matsuno D; Sato N; Furuya Y
Hinyokika Kiyo; 2007 Mar; 53(3):193-5. PubMed ID: 17447492
[TBL] [Abstract][Full Text] [Related]
10. [Successful complete androgen blockade (CAB) therapy for prostatic cancer detected from multiple lung metastases: a case report].
Tokumitsu M; Inada F; Kitahara K; Kawakami N; Masui N; Ishida H; Ishida H; Saga Y; Hashimoto H; Yachiku S
Hinyokika Kiyo; 2001 Jan; 47(1):59-62. PubMed ID: 11235226
[TBL] [Abstract][Full Text] [Related]
11. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
[TBL] [Abstract][Full Text] [Related]
12. [A case of prostatic carcinoma presenting as a metastatic orbital tumor].
Sakai H; Igawa T; Saha PK; Nomata K; Yushita Y; Kanetake H; Saito Y
Hinyokika Kiyo; 1992 Jan; 38(1):77-80. PubMed ID: 1546575
[TBL] [Abstract][Full Text] [Related]
13. Prostate adenocarcinoma with orbital metastasis in an HIV+ man.
Heintz J; Kahn B; Kramer A
Can J Urol; 2011 Apr; 18(2):5660-2. PubMed ID: 21504657
[TBL] [Abstract][Full Text] [Related]
14. [Multiple myeloma diagnosed during hormonal therapy for prostate cancer: report of two cases].
Yoshinaga A; Okada Y; Ichiyanagi N; Kamata S
Hinyokika Kiyo; 2012 May; 58(5):243-7. PubMed ID: 22767278
[TBL] [Abstract][Full Text] [Related]
15. Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapy.
Miller N; Smolkin ME; Bissonette E; Theodorescu D
Cancer; 2005 Jun; 103(12):2499-506. PubMed ID: 15852361
[TBL] [Abstract][Full Text] [Related]
16. Prostatic adenocarcinoma presenting with metastatic frontal bone involvement and orbital invasion.
Patel V; Castell FA; Akinwunmi J; Francis I; Chandrasekharan L; Malhotra R
Orbit; 2010 Aug; 29(4):213-5. PubMed ID: 20812840
[TBL] [Abstract][Full Text] [Related]
17. [Orbital metastasis of prostatic carcinoma].
El Mejjad A; Jouhadi H; Fekak H; Rabii R; Bennani S; Benider A; El Mrini M
Prog Urol; 2005 Feb; 15(1):85-8. PubMed ID: 15822401
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes of androgen deprivation as the sole therapy for localized and locally advanced prostate cancer.
Janoff DM; Peterson C; Mongoue-Tchokote S; Peters L; Beer TM; Wersinger EM; Mori M; Garzotto M
BJU Int; 2005 Sep; 96(4):503-7. PubMed ID: 16104900
[TBL] [Abstract][Full Text] [Related]
19. Intermittent androgen deprivation for patients with recurrent/metastatic prostate cancer.
Youssef E; Tekyi-Mensah S; Hart K; Bolton S; Forman J
Am J Clin Oncol; 2003 Oct; 26(5):e119-23. PubMed ID: 14528085
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a pituitary adenoma following a gonadotropin-releasing hormone agonist in a patient with prostate cancer.
Massoud W; Paparel P; Lopez JG; Perrin P; Daumont M; Ruffion A
Int J Urol; 2006 Mar; 13(3):303-4. PubMed ID: 16643633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]